United Health Products, Inc. (UEEC)
2025-06-30 | 2024-09-30 | 2024-06-30 | ||
|---|---|---|---|---|
| Revenues | - | - | - | |
| Selling, general and administrative expenses | 187,373 | 326,018 | 339,457 | |
| Research and development | 80,983 | 65,885 | 65,720 | |
| Total operating expenses | 268,356 | 391,903 | 405,177 | |
| Loss from operations | -268,356 | -391,903 | -405,177 | |
| Loss on settlement of debt | - | 115,085 | - | |
| Interest expense - related party | - | 19,231 | 19,231 | |
| Interest expense | 25,100 | 7,613 | 7,613 | |
| Interest expense - related party | 21,731 | - | - | |
| Loss on settlement of debt | - | - | - | |
| Total other income (expenses) | -46,831 | 88,241 | -26,844 | |
| Net loss | -315,187 | -303,662 | -432,021 | |
| Net (loss) | - | -303,662 | - | |
| Basic eps | - | - | - | |
| Basic and diluted | - | - | - | |
| Weighted average number of shares outstanding | 257,139,815 | 248,614,744 | 247,717,837 | |